Key result
Current smoking is linked to increased perioperative AF risk but does not modify colchicine efficacy.
Why the study?
To determine the association between smoking and perioperative AF and MINS after major noncardiac thoracic surgery, and whether colchicine effects varied by smoking status.
Does smoking status modify the effect of colchicine on perioperative atrial fibrillation and myocardial injury in patients undergoing major noncardiac thoracic surgery?
RCT (n=3,209)
Placebo-controlled
Randomized
Does smoking status modify the effect of colchicine on perioperative atrial fibrillation and myocardial injury in patients undergoing major noncardiac thoracic surgery?
Current smoking is associated with a small increased risk of perioperative atrial fibrillation after major thoracic surgery, but smoking status does not modify the lack of efficacy of colchicine in preventing perioperative AF or MINS.
Answers are grounded in this paper and cite their sources.
Smoking warrants attention in perioperative AF risk stratification for thoracic surgery; confirms colchicine's neutral effect is unmodified by smoking status.
Background: To determine, among patients who underwent major noncardiac thoracic surgery, the association between smoking and perioperative atrial fibrillation (AF) and myocardial injury after noncardiac surgery (MINS), and whether the effect of colchicine use on these outcomes varied by smoking status. Methods: This study is a subgroup analysis of the Colchicine for the Prevention of Perioperative Atrial Fibrillation (COP-AF) randomized clinical trial. A total of 3209 participants who underwent major noncardiac thoracic surgery were randomized to receive colchicine, 0.5 mg twice daily, or identical placebo, for 10 days starting 2-4 hours before surgery. The co-primary outcomes were clinically significant perioperative AF and MINS during the 14-day follow-up. Conclusions: Current smoking was associated with a small but increased risk of perioperative AF but not MINS after thoracic surgery. The effect of colchicine use on either outcome was not modified by smoking status. Clinical Trial Registration: NCT03310125.
No takes yet. Share an insight, caveat, or question.
Ofori et al. (2025) conducted an RCT in Major noncardiac thoracic surgery (n=3,209). Colchicine vs. Identical placebo was evaluated on Clinically significant perioperative AF and myocardial injury after noncardiac surgery (MINS) during the 14-day follow-up (p=0.08). Current smoking was associated with an increased risk of perioperative AF but not MINS after thoracic surgery, and the effect of colchicine on these outcomes was not modified by smoking status.
Synapse has enriched 10 related papers. Consider them for comparative context: